Anti-Aging-Guide.com
home
Printable Version
To print this page, please select File/Print from your browser's menu
 
 
AGING AND ANTI-AGING. WHY DO WE AGE?
 
 2.1 AGING FORCES (forces that cause aging) 
   
 
  INTERNAL & EXTERNAL   
   
 
   INTERNAL aging forces in the body: 
   
 

8. Neuro-hormonal disregulation

 


 
   
   

2005

Ned Tijdschr Geneeskd. 2005 May 7;149(19):1033-7.
[Hormonal and metabolic causes of muscular weakness and the increased risk of fractures in elderly people]
[Article in Dutch]

Nieuwenhuijzen Kruseman AC, van der Klauv MM, Pijpers E.
Academisch Ziekenhuis Maastricht, afd. Inwendige Geneeskunde, Postbus 5800, 6202 AZ, Maastricht.

The increased risk of fractures in elderly people is due not only to a decrease in bone mass and bone quality but also to an increased risk of falling. The increased risk of falling is partly a consequence of muscular weakness caused by a decrease in both muscular mass and strength (sarcopenia), in which the hormonal changes that are typical of aging play a pivotal role, as well as of malnutrition, in particular a deficiency of protein, amino acids, calcium and vitamin D. Measures that limit the risk of falling and fractures due to muscular weakness consist mainly of adequate nutrition, extra calcium and vitamin D, reduction of the factors that increase the risk of falling, weight-bearing exercise to strengthen the muscles and the use of hip protectors. Hormonal suppletion has not yet been shown to have a favourable effect, whereas the disadvantages appear to be substantial.

   
   
Obes Res. 2005 Apr;13(4):717-28.
Dysregulation of the Autonomic Nervous System Can Be a Link between Visceral Adiposity and Insulin Resistance.
Lindmark S, Lonn L, Wiklund U, Tufvesson M, Olsson T, Eriksson JW.
Department of Medicine, Umea University Hospital, S-901 85 Umea, Sweden.

OBJECTIVE: To evaluate the interplay among abdominal adipose tissue distribution, the cortisol axis, the autonomic nervous system, and insulin resistance. RESEARCH METHODS AND PROCEDURES: Two age-, sex-, and BMI-matched groups were studied. Fifteen subjects were first-degree relatives of patients with type 2 diabetes (R), and 15 had no family history of diabetes (controls, C). A hyperinsulinemic euglycemic clamp, cortisol measurements, and analysis of heart rate variability (HRV) were performed. Computed tomography was performed in a subgroup (n = 9 + 9) to determine abdominal adipose tissue distribution. RESULTS: R tended to be less insulin-sensitive than C (M value 9.2 +/- 1.0 vs 10.3 +/- 0.7 mg/kg per minute, not significant). Stimulation with tetracosactin or corticotropin releasing hormone yielded lower peak serum cortisol levels in R (p = 0.03 and p = 0.06, respectively). The amount of visceral abdominal fat (VAT) tended to be greater in R. In all subjects, VAT was negatively correlated to insulin sensitivity (r = -0.93, p < 0.001). There was a positive association between VAT and resting heart rate (r = 0.70, p = 0.003) and sympathetic/parasympathetic ratio in HRV assessment after tilt (r = 0.53, p = 0.03). Subcutaneous abdominal tissue was not associated with insulin sensitivity or any of the hormonal or HRV assessments. DISCUSSION: Subjects genetically predisposed for type 2 diabetes had a tendency toward a larger amount of VAT and to lower insulin sensitivity compared with control subjects. The amount of visceral fat was strongly associated with insulin resistance and signs of a high ratio of sympathetic vs. parasympathetic reactivity. A large amount of visceral fat may act in concert with sympathetic/parasympathetic imbalance to promote the development of insulin resistance, and this may be partly independent of genetic background.

   
   

2004

Int J Obes Relat Metab Disord. 2004 Nov;28 Suppl 3:S46-53.
Programming of obesity and cardiovascular disease.
Remacle C, Bieswal F, Reusens B.
Laboratory of Cell Biology, Institute of Life Science, Universite Catholique de Louvain, Louvain-la-Neuve B 1348, Belgium.

BACKGROUND: There is evidence that malnutrition in early life induces a growth retardation leading, in adult life, to manifest components of the metabolic syndrome. However, the impact on obesity seems less clearly established. OBJECTIVE: To review the effects of foetal and postnatal malnutrition on the programming of obesity in the context of the metabolic syndrome, as well as the link between central obesity and cardiovascular diseases. METHODS: Included in the review were recent papers exploring the mechanisms linking maternal nutrition with impaired foetal growth and later obesity, cardiovascular disease, hypertension and diabetes in humans and animals. RESULTS: The programming of obesity during foetal and early postnatal life depends of the timing of maternal malnutrition as well as the postnatal environment. Obesity arises principally in offspring submitted to malnutrition during early stages of gestation and which presented early catch-up growth. The programming may involve the dysregulation of appetite control or the hormonal environment leading to a context favourable to obesity development (hypersecretion of corticosteroids, hyperinsulinaemia and hyperleptinaemia and anomalies in the IGF axis). Adipose tissue secretes actively several factors implicated in inflammation, blood pressure, coagulation and fibrinolysis. The programmed development of intra-abdominal obesity after early growth restriction may thus favour higher prevalence of hypertension and cardiovascular diseases. CONCLUSIONS: Abdominal obesity appears in malnourished offspring and is aggravated by early catch-up growth. Higher rates of intra-abdominal obesity observed after growth restriction may participate to hypertension and create atherothrombotic conditions leading to the development of cardiovascular diseases.

   
   

1995

Neurobiol Aging 1995 Sep-Oct;16(5):837-43; discussion 855-6
Neuroendocrine involvement in aging: evidence from studies of reproductive aging and caloric restriction.
Nelson JF, Karelus K, Bergman MD, Felicio LS.
Department of Physiology, University of Texas Health Science Center, San Antonio 78284-7756, USA.

Neuroendocrine changes contribute to female reproductive aging, but changes in other tissues also play a role. In C57BL/6J mice, neuroendocrine changes contribute to estrous cycle lengthening and reduced plasma estradiol levels, but the midlife loss of cyclicity is mainly due to ovarian failure. Hypothalamic estrogen receptor dynamics and estrogenic modulation of gene expression are altered in middle-aged cycling mice. Although insufficient to arrest cyclicity, these neuroendocrine changes may contribute to other reproductive aging phenomena, such as altered gonadotropin secretion and lengthened estrous cycles. In women, the loss of ovarian oocytes, the cause of menopause, accelerates in the decade before menopause. Accelerated oocyte loss may in turn be caused by a selective elevation of plasma follicle stimulating hormone, and neuroendocrine involvement may thus be implicated in menopausal oocyte loss. Chronic calorie restriction retards both neural and ovarian reproductive aging processes, as well as age-related change in many other physiological systems. The diverse effects of food restriction raises the possibility of an underlying coordinated regulatory response of the organism to reduced caloric intake, possibly effected through alterations of neural and/or endocrine signalling. We are therefore attempting to identify neuroendocrine changes that may coordinate the life prolonging response of animals to food restriction. Our initial focus is on the glucocorticoid system. Food restricted rats exhibit daily periods of hyperadrenocorticism, manifest as elevated free corticosterone during the diurnal peak. We hypothesize that this hyperadrenocortical state potentiates cellular and organismic homeostasis throughout life in a manner similar to that achieved during acute stress, thereby retarding aging processes and extending life span.

   
   

1989

J Gerontol 1989 Nov;44(6):B139-47
Aging and anti-aging effects of hormones.
Everitt A, Meites J.
University of Sydney, Australia.

Hormones can promote or inhibit aging depending on the experimental conditions employed. The aging effects of hormones are demonstrated by reducing hormone secretion by hypophysectomy or chronic underfeeding in young or mature rats. These result in depressing whole body metabolism, growth, body temperature and blood glucose levels, heart rate and vital capacity, gene expression, etc., but delaying aging of tissues, suppressing development of pathology and tumors, and, in underfed rats, prolonging life span. The anti-aging effects of hormones are demonstrated by elevating hormone levels in old rats whose hormones have declined as a result of dysfunctions that develop in the neuroendocrine system with age. An increase of hormones in these rats promotes gene expression, elevates protein synthesis, and enhances metabolism, growth, and function of stimulated organs and tissues.